Search results
TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
Clinical Trials Arena via Yahoo Finance· 6 hours agoFinnish biotechnology company TILT Biotherapeutics has announced results from a Phase I clinical ...
North Carolina clinical trial success leads to new breast cancer treatment
WXII-TV Winston-Salem· 2 hours agoDonna Huie always heard people describe a cancer diagnosis as a "punch to the gut." An extra...
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major...
Digital Journal· 4 hours agoPhase 2, Proof-of-Concept X-NOVA Study” May 29, 2024 at 11:15 am to 1 pm ET in Salon 4 The Company’s presentations summarize clinical ...
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / NCNP-01) Phase 3 Clinical Trial...
The Woonsocket Call· 1 day agoNS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd., announced today that it has received preliminary analysis results from the global Phase< ...
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Clinical Trials Arena via Yahoo Finance· 3 hours agoFollowing the positive results, the company now plans to start a global Phase III clinical trial...
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 9 hours agoThe trial enrolled 388 patients across 70 sites in nine countries. Patients were randomised 1:1...
Transcenta’s Osemitamab succeeds in Phase IIa G/GEJ cancer triple combo trial
Clinical Trials Arena via Yahoo Finance· 6 hours agoThe TranStar102 study (NCT04495296) investigated osemitamab in combination with Opdivo (nivolumab)...
...Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and...
NBC 10 - FOX 14 Monroe· 4 days agoTyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the ...
Innovent’s psoriasis treatment picankibart meets all endpoints in Phase III trial
Clinical Trials Arena via Yahoo Finance· 7 hours agoCLEAR-1 is claimed to be the first Phase III trial in the IL-23p19 class to report more than 80% of...
Neuren Pharmaceuticals’ NNZ-2591 shows promise in trial for Pitt Hopkins syndrome
Clinical Trials Arena via Yahoo Finance· 5 hours agoThe trial began with a minimum four-week screening period to establish baseline characteristics...